Loading your page…
Stroke Vascular and Interventional Neurology
By Stavros Matsoukas, Amol M. Mehta, Johanna T Fifi and 22 others.
Ward brings these articles into the same app as your cards and questions. One free account for Ward, Suture, Osler and Prognia.
Endovascular thrombectomy is increasingly performed for acute ischemic stroke due to medium vessel occlusion (MeVO); however, recent randomized trials—primarily using stent retriever (SR) techniques—have not demonstrated a clear benefit over medical management. This study aimed to compare the direct aspiration first-pass technique (ADAPT) and SR in MeVO using a multicenter endovascular thrombectomy consortium.
The Society of Vascular and Interventional Neurology registry was queried for all primary MeVO cases treated with ADAPT or SR as the first-pass technique. MeVO was defined as an occlusion of A1, P1, M2, or beyond. Outcomes included time to recanalization, recanalization rates, first-pass effect (defined as treatment in cerebral infarction-3 after first pass), intracranial hemorrhage, symptomatic intracranial hemorrhage, and clinical outcomes.
A total of 1391 patients with MeVO were identified; 415 (29.8%) in the ADAPT group and 976 (70.2%) in the SR group. The most common location of occlusion was the middle cerebral artery-M2 (75.9%), followed by the middle cerebral artery-M3 (11.4%). The median age was 70, and 698 (50.4%) patients were men. Time from angio-suite arrival to expanded Treatment in Cerebral Infarction (eTICI) ≥2b (54 versus 60, P =0.002), time from endovascular access to final recanalization (42 versus 52, P <0.001), time from endovascular access to eTICI 2b (31 versus 39, P <0.001), and eTICI 3 (26 versus 34, P <0.001) were shorter for the ADAPT group. Conversely, the SR group had higher rates of eTICI ≥2b (91.6% versus 86.3%, P =0.002) and first-pass effect (31.7% versus 23.4%, P =0.002). Rates of good outcome, excellent outcome, intracranial hemorrhage, and sICH were not significantly different between groups.
Although ADAPT yielded faster recanalization, SR achieved a higher first-pass effect and slightly higher recanalization rates. Intracranial hemorrhage, symptomatic intracranial hemorrhage, and clinical outcomes were comparable between groups. This study suggests that both techniques may offer distinct advantages. Prospective randomized controlled studies are warranted to further understand the safety and efficacy of ADAPT versus the SR technique in patients with MeVO.
Published in Stroke Vascular and Interventional Neurology. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
